Patricia LoRusso
0000-0001-7144-036X
1 paper found
Refreshing results…
The MDM2–p53 Antagonist Brigimadlin (BI 907828) in Patients with Advanced or Metastatic Solid Tumors: Results of a Phase Ia, First-in-Human, Dose-Escalation Study
Missing publications? Search for publications with a matching author name.